Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record.

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

Open access
Castle, P. E, Rodriguez, A. C., Burk, R. D, Herrero, R., Wacholder, S., Alfaro, M., Morales, J., Guillen, D., Sherman, M. E, Solomon, D., Schiffman, M., for the Proyecto Epidemiologico Guanacaste (PEG) Group · 2009 · BMJ

Abstract

OBJECTIVE: To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence of prevalently detected carcinogenic human papillomavirus (HPV). DESIGN: Population based cohort study. SETTING: Guanacaste, Costa Rica. PARTICIPANTS: 2282 sexually active women actively followed after enrolment. MAIN OUTCOME MEASURES: Primary end points: three year and five year cumulative incidence of histologically confirmed cervical intraepithelial neoplasia grade II+ (n=70). Cervical specimens collected at each visit tested for more than 40 HPV genotypes. HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, and 82 were considered the primary carcinogenic genotypes. RESULTS: Women who tested positive for a carcinogenic HPV at enrolment and after about one year (9-21 months) (positive/positive) had a three year cumulative incidence of cervical intraepithelial neoplasia grade II+ of 17.0% (95% confidence interval 12.1% to 22.0%). Those who tested negative/positive (3.4%, 0.1% to 6.8%), positive/negative (1.2%, -0.2% to 2.5%), and negative/negative (0.5%, 0.1% to 0.9%) were at a significantly lower risk. There was little difference in the cumulative incidence of cervical intraepithelial neoplasia grade II+ between testing positive twice for any carcinogenic HPV genotype (same genotype or different genotypes) v testing positive twice for the same carcinogenic genotype (17.0% v 21.3%, respectively). Short term persistence of HPV 16 strongly predicted cervical intraepithelial neoplasia grade II+, with a three year cumulative incidence of 40.8% (26.4% to 55.1%). Similar patterns were observed for the five year cumulative incidence of grade II+ and for three year and five year cumulative incidence of grade III+. CONCLUSIONS: Short term persistence of a prevalently detected carcinogenic HPV infection, especially HPV 16, strongly predicts a subsequent diagnosis of cervical intraepithelial neoplasia II+ over the next few years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.b2569

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 211

Metadata

Authors
Castle, P. E., Rodriguez, A. C., Burk, R. D., Herrero, R., Wacholder, S., Alfaro, M., Morales, J., Guillen, D., Sherman, M. E., Solomon, D., Schiffman, M., & for the Proyecto Epidemiologico Guanacaste (PEG) Group
Venue
BMJ
Publisher
BMJ
Published
2009-07-28
Volume
339
Issue
jul28 2
Pages
b2569-b2569
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2066009669
Cited by
211
References
0
FWCI
15.22
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. https://app.cochat.ai/papers/10.1136/bmj.b2569
The paper
Castle, P. E., Rodriguez, A. C., Burk, R. D., Herrero, R., Wacholder, S., Alfaro, M., Morales, J., Guillen, D., Sherman, M. E., Solomon, D., Schiffman, M., & for the Proyecto Epidemiologico Guanacaste (PEG) Group. (2009). Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ. https://doi.org/10.1136/bmj.b2569

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.